SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs HealthCCSng

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

HealthCCSng

by Nano-X AI

AI Verdict

Tool A assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals, ideal for point-of-care assessment using a stethoscope. In contrast, Tool B analyzes routine CT scans to detect and quantify coronary artery calcification, providing insights into coronary artery disease risk. While both are cardiology AI tools, they address distinct diagnostic needs using different data modalities.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI if your primary need is real-time, AI-powered assistance in differentiating heart murmurs during a physical examination. This tool is ideal for clinicians who regularly auscultate patients and require immediate decision support to distinguish between physiological and pathological sounds at the point of care, aiding in prompt referral or further investigation.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose HealthCCSng if…

Choose HealthCCSng if your goal is to leverage existing routine CT scans for automated, large-scale detection and quantification of coronary artery calcification. This solution is best suited for healthcare systems and specialists like radiologists and cardiologists aiming to proactively identify patients at risk of coronary artery disease by integrating CAC assessment into their standard imaging workflows.

View HealthCCSng →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	HealthCCSng
Pricing	Contact for pricing	Not publicly available
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Cloud-based, integrates with PACS and EMR systems
BAA Available	Yes AI-estimated	Unknown
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

HealthCCSng

Tool B, HealthCCSng, offers superior usability due to its cloud-based deployment and seamless integration with existing PACS and EMR systems, facilitating an automated workflow for results without human intervention. This contrasts with Tool A, SensiCardiac Mobi, which, while having positive user scores for its mobile interface, requires a specific mobile device and user-provided stethoscope, implying a more active, hands-on approach during patient examination.

Clinical Value

HealthCCSng

Both tools are FDA-cleared and provide clinical value. However, HealthCCSng (Tool B) demonstrates a more significant clinical impact by leveraging routine CT scans to identify a high percentage of previously undetected patients at risk of coronary artery disease, leading to improved patient follow-up and treatment pathways. Clinical studies show that 58% of patients unknowingly had moderate to severe levels of coronary artery calcium, a proven indicator of future cardiac events, which HealthCCSng can detect.

Pricing & Value

HealthCCSng

While neither tool publicly discloses pricing, HealthCCSng (Tool B) explicitly highlights its value proposition through the availability of CPT codes for reimbursement (0721T, 0722T) and documented instances of generating substantial revenue for healthcare systems. This transparency regarding a reimbursement pathway and proven financial benefits provides a clearer understanding of its economic value compared to SensiCardiac Mobi (Tool A), which offers no public pricing or reimbursement details.

Enterprise Readiness

HealthCCSng

HealthCCSng (Tool B) is more enterprise-ready due to its cloud-based architecture and seamless integration capabilities with PACS and EMR systems, which are critical for large-scale hospital deployments and streamlined workflows. SensiCardiac Mobi (Tool A), while HIPAA compliant and offering a BAA, relies on a hosted server environment with a mobile application interface, which may require more bespoke integration and management within complex enterprise IT infrastructures.

Innovation

HealthCCSng

Both tools are innovative in their respective domains. However, HealthCCSng (Tool B) presents a more impactful innovation by opportunistically detecting and quantifying coronary artery calcification from routine, non-gated, non-contrast CT scans that were originally performed for other indications. This approach extracts new, critical cardiac risk information from existing data without additional patient burden or dedicated scans, offering a highly efficient and scalable method for preventive care.

Support & Docs

Tie

Neither SensiCardiac Mobi (Tool A) nor HealthCCSng (Tool B) provides sufficient publicly available information regarding their specific support services or comprehensive documentation. Without detailed information on customer support channels, service level agreements, or user manuals, it is not possible to distinguish between the two tools in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	HealthCCSng
Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	HealthCCSng
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	Nano-X AI
Primary Diagnostic Focus	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals to differentiate between physiological and pathological sounds.	Analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease.
Input Data Type	Acoustic heart signals from an electronic stethoscope	Non-contrast, non-ECG gated chest CT scans
Key Output/Analysis	Distinguishes between normal/physiological and pathological heart murmurs; Identifies S1, S2, and suspected murmurs.	Automatically detects and quantifies coronary artery calcification (CAC); Categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC; Generates a numerical calcium score; Provides visualization of calcified plaques.
System Integration	Mobile application for data capture and display (e.g., iPhone 4S or later); Requires a compatible electronic stethoscope (user-provided).	Seamless integration with PACS and EMR systems.
Target Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and HealthCCSng.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems, and what is the level of automation for each?

SensiCardiac Mobi operates as a mobile application for data capture and display, requiring a compatible electronic stethoscope and complementing physician assessment. HealthCCSng offers seamless integration with PACS and EMR systems, providing an automated workflow for results without human intervention by analyzing routine CT scans.

Can you elaborate on the accuracy and sensitivity of each tool in its respective diagnostic area, and how does this complement a physician's assessment?

SensiCardiac Mobi's AI-powered algorithm analyzes acoustic heart signals to differentiate between physiological and pathological heart murmurs, identifying S1, S2, and suspected murmurs, acting as decision support. HealthCCSng automatically detects and quantifies coronary artery calcification from CT scans, categorizing studies and generating a numerical calcium score to empower physicians in assessing coronary artery disease risk.

In what specific clinical scenarios or patient populations would each tool be most beneficial, considering their distinct functions?

SensiCardiac Mobi is beneficial in cardiology, internal medicine, and pediatrics for real-time auscultation and immediate diagnostic support in differentiating heart murmurs. HealthCCSng is tailored for cardiology and radiology, assisting in the assessment of coronary artery disease risk by analyzing routine CT scans for coronary artery calcification.

What is the expected learning curve for physicians and staff to effectively utilize each tool, and what is the typical time-to-value for realizing clinical benefits?

SensiCardiac Mobi involves using a mobile application with a user-provided electronic stethoscope, suggesting a learning curve related to the mobile interface and stethoscope operation. HealthCCSng, with its automated workflow and integration with PACS and EMR systems, likely has a different learning curve focused on interpreting the automated CAC results within existing imaging workflows.

What audit-trail features are available to track the use of the tools, generated results, and physician interactions for quality assurance or clinical review?

The provided information does not explicitly detail specific audit-trail features for either SensiCardiac Mobi or HealthCCSng. However, both are medical devices operating in clinical settings, implying a need for such capabilities for accountability and quality assurance.

For healthcare systems with multiple sites, what are the key considerations for implementing and scaling each solution across different locations?

For multi-site rollouts, SensiCardiac Mobi would require managing mobile application deployment and compatible electronic stethoscopes across sites. HealthCCSng, being cloud-based with PACS and EMR integration, would focus on ensuring seamless system integration and data flow across various hospital sites.